Search results
Author(s):
Charles Simonton
,
Craig Thompson
,
Jason R Wollmuth
,
et al
Added:
3 years ago
Coronary artery disease (CAD) is a leading cause of morbidity and mortality globally, despite advances in medical and preventive therapy. It is estimated that 18.2 million adults in the US have CAD, with 720,000 Americans projected to have a first hospitalization for MI or CAD death this year.1 Treatment of patients with symptomatic CAD includes guideline-directed medical therapy and coronary…
View more
Author(s):
Jimmy Kerrigan
,
Timir K Paul
,
Jay Patel
,
et al
Added:
6 months ago
Author(s):
Abdulrahman Almoghairi
,
Nayef Al-Asiri
,
Khalid Al Johani
,
et al
Added:
9 months ago
Author(s):
Marvin J Slepian
Added:
3 years ago
Heart failure remains the final common pathway of all forms of heart disease. Currently, more than 20 million patients suffer with heart failure in the US and Europe combined.1 Over the past two decades, advances in medical therapeutics have made inroads in reducing mortality associated with early- and mid-stage heart failure. Unfortunately, once patients progress to advanced heart failure, i.e…
View more
Rodrigo Bagur
Job title: Interventional Cardiologist
Author
Gerald Werner
Job title: MD
Author
Author(s):
Michael M McNally
,
Michael C Stoner
Added:
3 years ago
Treatment for blood clots and their life-threatening sequelae has expanded significantly over the past 50 years. Thrombolytic therapy has gained widespread acceptance and use. Advances in technology have led to experiments with catheter-directed thrombolytic therapy in combination with other physical modality delivery systems, such as ultrasound, to improve the efficacy of thrombolytic therapy…
View more
Author(s):
Rafael Romaguera
Added:
2 years ago
In this short interview, Dr Rafael Romaguera (University of Barcelona, SP) discusses the findings from the SUGAR trial.This randomized head-to-head trial aimed to compare Cre8 EVO stents to a contemporary drug-eluting stent (DES) in patients with diabetes (DM) and coronary artery disease. The trial, first presented at TCT 2021, demonstrated that Cre8 EVO stents were non-inferior to Resolute Onyx…
View more
Aspirin and Statins to Decrease Risks of Cardiovascular Disease – The Need for Wider Utilization
Author(s):
Charles H Hennekens
,
Danielle Hollar
,
Arthur S Agatston
Added:
3 years ago
Article
Embolic Protection
Author(s):
Jennifer Franke
,
Horst Sievert
Added:
3 years ago
Article